The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...

PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...

Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification ...

How Techceuticals, PharmParts, and smart auction strategies are ushering in a new era of efficiency and innovation for CDMOs ...

The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...